Current Delivery Methods: Injectable, Oral, and Compounded Options Three delivery pathways currently dominate GLP-1 therapy: subcutaneous injectables (weekly or daily), oral tablets, and compounded formulations through licensed 503A pharmacies
References McCoy AT, Benoist CC, Wright JW, Kawas LH, Bule-Ghogare JM, Zhu M, Appleyard SM, Wayman GA, Harding JW
HIF-1 is usually activated under hypoxic conditions and then regulates the expression of multiple genes, thereby altering the physiological processes of the body under hypoxic conditions
For example, IPP is critical for maturation of GPX4 20 , the first reported protein to protect cells from ferroptosis
The result is a sustained elevation of GH and IGF-1 rather than a single discrete pulse, which is why tesamorelin is dosed continuously rather than in cycles